KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Labcorp Holdings (LH) Total Debt (2016 - 2025)

Labcorp Holdings (LH) has disclosed Total Debt for 17 consecutive years, with $5.6 billion as the latest value for Q4 2025.

  • Quarterly Total Debt fell 11.79% to $5.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.6 billion through Dec 2025, down 11.79% year-over-year, with the annual reading at $5.6 billion for FY2025, 11.79% down from the prior year.
  • Total Debt hit $5.6 billion in Q4 2025 for Labcorp Holdings, up from $5.1 billion in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $6.3 billion in Q4 2024 to a low of $3.0 billion in Q2 2024.
  • Historically, Total Debt has averaged $5.1 billion across 5 years, with a median of $5.3 billion in 2022.
  • Biggest five-year swings in Total Debt: plummeted 39.68% in 2024 and later surged 82.72% in 2025.
  • Year by year, Total Debt stood at $5.4 billion in 2021, then fell by 1.44% to $5.3 billion in 2022, then decreased by 5.35% to $5.1 billion in 2023, then rose by 25.26% to $6.3 billion in 2024, then dropped by 11.79% to $5.6 billion in 2025.
  • Business Quant data shows Total Debt for LH at $5.6 billion in Q4 2025, $5.1 billion in Q3 2025, and $5.1 billion in Q2 2025.